327 related articles for article (PubMed ID: 17156337)
21. Proteoglycans are potent modulators of the biological responses of eosinophils to chemokines.
Culley FJ; Fadlon EJ; Kirchem A; Williams TJ; Jose PJ; Pease JE
Eur J Immunol; 2003 May; 33(5):1302-10. PubMed ID: 12731055
[TBL] [Abstract][Full Text] [Related]
22. Differential pattern of CCR1 internalization in human eosinophils: prolonged internalization by CCL5 in contrast to CCL3.
Elsner J; Dulkys Y; Gupta S; Escher SE; Forssmann WG; Kapp A; Forssmann U
Allergy; 2005 Nov; 60(11):1386-93. PubMed ID: 16197470
[TBL] [Abstract][Full Text] [Related]
23. Eotaxin-3/CC chemokine ligand 26 is a functional ligand for CX3CR1.
Nakayama T; Watanabe Y; Oiso N; Higuchi T; Shigeta A; Mizuguchi N; Katou F; Hashimoto K; Kawada A; Yoshie O
J Immunol; 2010 Dec; 185(11):6472-9. PubMed ID: 20974991
[TBL] [Abstract][Full Text] [Related]
24. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
Parody TR; Stone MJ
Cytokine; 2004 Jul; 27(1):38-46. PubMed ID: 15207250
[TBL] [Abstract][Full Text] [Related]
25. Differential activation of CC chemokine receptors by AOP-RANTES.
Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
[TBL] [Abstract][Full Text] [Related]
26. Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation.
Hsu YH; Hsieh MS; Liang YC; Li CY; Sheu MT; Chou DT; Chen TF; Chen CH
J Cell Biochem; 2004 Nov; 93(5):929-39. PubMed ID: 15389872
[TBL] [Abstract][Full Text] [Related]
27. The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts.
Puxeddu I; Bader R; Piliponsky AM; Reich R; Levi-Schaffer F; Berkman N
J Allergy Clin Immunol; 2006 Jan; 117(1):103-10. PubMed ID: 16387592
[TBL] [Abstract][Full Text] [Related]
28. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
29. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.
White JR; Imburgia C; Dul E; Appelbaum E; O'Donnell K; O'Shannessy DJ; Brawner M; Fornwald J; Adamou J; Elshourbagy NA; Kaiser K; Foley JJ; Schmidt DB; Johanson K; Macphee C; Moores K; McNulty D; Scott GF; Schleimer RP; Sarau HM
J Leukoc Biol; 1997 Nov; 62(5):667-75. PubMed ID: 9365122
[TBL] [Abstract][Full Text] [Related]
30. Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.
Jiang PJ; Lin QD; Bao SM; Zhao AM; Zhang Y; Xiao SJ
Chin Med J (Engl); 2009 Feb; 122(4):390-5. PubMed ID: 19302742
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional characterization of CC chemokine CCL14.
Blain KY; Kwiatkowski W; Zhao Q; La Fleur D; Naik C; Chun TW; Tsareva T; Kanakaraj P; Laird MW; Shah R; George L; Sanyal I; Moore PA; Demeler B; Choe S
Biochemistry; 2007 Sep; 46(35):10008-15. PubMed ID: 17691823
[TBL] [Abstract][Full Text] [Related]
32. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
33. Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: implications for myelination.
Maysami S; Nguyen D; Zobel F; Heine S; Höpfner M; Stangel M
J Neuroimmunol; 2006 Sep; 178(1-2):17-23. PubMed ID: 16828880
[TBL] [Abstract][Full Text] [Related]
34. Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.
Crump MP; Spyracopoulos L; Lavigne P; Kim KS; Clark-lewis I; Sykes BD
Protein Sci; 1999 Oct; 8(10):2041-54. PubMed ID: 10548050
[TBL] [Abstract][Full Text] [Related]
35. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
36. Distinct but overlapping epitopes for the interaction of a CC-chemokine with CCR1, CCR3 and CCR5.
Pakianathan DR; Kuta EG; Artis DR; Skelton NJ; Hébert CA
Biochemistry; 1997 Aug; 36(32):9642-8. PubMed ID: 9289016
[TBL] [Abstract][Full Text] [Related]
37. Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
Mayer KL; Stone MJ
Proteins; 2003 Feb; 50(2):184-91. PubMed ID: 12486712
[TBL] [Abstract][Full Text] [Related]
38. Pyrrolidinohydroquinazolines--a novel class of CCR3 modulators.
Anderskewitz R; Bauer R; Bodenbach G; Gester D; Gramlich B; Morschhäuser G; Birke FW
Bioorg Med Chem Lett; 2005 Feb; 15(3):669-73. PubMed ID: 15664834
[TBL] [Abstract][Full Text] [Related]
39. In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.
Borchers MT; Ansay T; DeSalle R; Daugherty BL; Shen H; Metzger M; Lee NA; Lee JJ
J Leukoc Biol; 2002 Jun; 71(6):1033-41. PubMed ID: 12050190
[TBL] [Abstract][Full Text] [Related]
40. Localization and expression of CCR3 and CCR5 by interleukin-1 beta in the RIN-5AH insulin-producing model system: a protective mechanism involving down-regulation of chemokine receptors.
Vassiliadis S; Balabanidou V; Papadopoulos GK; Athanassakis I
JOP; 2002 May; 3(3):66-75. PubMed ID: 12004163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
